Vertex Software faces strong competition and slower growth, leading to a neutral rating. See why VERX stock remains pricey ...

Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to trigger sufficient levels of insulin production in a phase 1/2 trial.

You can cut through some of the election noise with Vote Compass, which returns for the 2025 federal election. You put in your postcode to narrow down to your electorate, answer 30 questions ...

We recently published a list of Jim Cramer Looked At These 23 Stocks Recently. In this article, we are going to take a look ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

“But the bottom line: It’s tricky to see such a broad mixture of stocks winning here, from ones that can run in a recession to ones that can rally hard in a robust economy. What it tells me is ...

Mutual funds remain at T. Rowe Price's core while Fidelity continues to evolve Amanda Jackson has expertise in personal finance, investing, and social services. She is a library professional ...

We acknowledge Aboriginal and Torres Strait Islander peoples as the First Australians and Traditional Custodians of the lands where we live, learn, and work.

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Schizophrenia affects ...

Another Sunday, another showdown! This week, we’re matching up two professional titanium dive watches that come in under €5K. The first is the recently introduced Seiko Prospex Marinemaster SLA081.

Justice Marlene Carter has ruled that the National Conservation Council cannot make any decisions until a court hearing next month to determine if a judicial review should go ahead into the ...

At close: April 2 at 4:00:00 PM EDT ...